Buying a few more shares on market at 26.5c.The directors were not permitted to participate in the recent cap raising at 25c.So I guess they simply did the next best thing-buy on market.All the best.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025